Literature DB >> 23294503

The fibrillin-1 hypomorphic mgR/mgR murine model of Marfan syndrome shows severe elastolysis in all segments of the aorta.

Simon Schwill1, Philipp Seppelt, Johannes Grünhagen, Claus-Eric Ott, Manfred Jugold, Arjang Ruhparwar, Peter N Robinson, Matthias Karck, Klaus Kallenbach.   

Abstract

OBJECTIVE: Fibrillin-1 hypomorphic mice (mgR/mgR) are accepted as a model of Marfan syndrome. Phenotypic investigations of this mouse have not previously included quantification of phenotypic features and detailed examinations of the histopathology other than in the ascending aorta.
METHODS: We developed a quantitative polymerase chain reaction assay to genotype the mice. Necropsy was performed on 50 male mice after natural death. We then sacrificed 10 mgR/mgR and 10 wild-type mice at 14-19 weeks to perform in vivo computed tomographic scans (n = 3) and microscopic examinations (n = 7). Four aortic segments (ascending, descending, pararenal, and infrarenal aorta) were excised. Each segment was divided into four subsegments and analyzed with Van Gieson staining. The number of elastin breaks and internal aortic diameter were determined twice in randomized, blinded fashion.
RESULTS: Computed tomographic scans of mgR/mgR mice revealed aneurysm formation in the ascending aorta and kyphoscoliosis. Elastolysis was present in all four aortic segments of mgR/mgR but was rarely observed in wild-type mice (P < .001). The diameter of the ascending aorta was larger in mgR/mgR than in wild-type mice (P = .01), but para- and infrarenal aortic diameter were even smaller in mgR/mgR mice (P < .001 and P = .01, respectively). Exploratory gene expression analysis showed a number of differentially expressed genes with overrepresentation of immune-related functions. Quantitative polymerase chain reaction analysis confirmed upregulation of selected genes in both the ascending aorta and the abdominal aorta.
CONCLUSIONS: Our findings suggest that mgR/mgR mice could be a useful model to study aortic abnormalities in segments other than the ascending aorta in order to understand the molecular mechanisms of aortic disease in Marfan syndrome.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294503     DOI: 10.1016/j.jvs.2012.10.007

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

1.  Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.

Authors:  Jungsil Kim; Jesse D Procknow; Hiromi Yanagisawa; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

2.  Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome.

Authors:  C Bellini; A Korneva; L Zilberberg; F Ramirez; D B Rifkin; J D Humphrey
Journal:  J Biomech       Date:  2015-12-22       Impact factor: 2.712

Review 3.  Central artery stiffness and thoracic aortopathy.

Authors:  J D Humphrey; G Tellides
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-09       Impact factor: 4.733

Review 4.  Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGFβ signaling and cell stemness.

Authors:  Francesco Ramirez; Cristina Caescu; Elisabeth Wondimu; Josephine Galatioto
Journal:  Matrix Biol       Date:  2017-08-04       Impact factor: 11.583

5.  Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.

Authors:  Nazli Gharraee; Yujian Sun; Joseph A Swisher; Susan M Lessner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-29       Impact factor: 4.733

6.  Loss of Elastic Fiber Integrity Compromises Common Carotid Artery Function: Implications for Vascular Aging.

Authors:  J Ferruzzi; M R Bersi; R P Mecham; F Ramirez; H Yanagisawa; G Tellides; J D Humphrey
Journal:  Artery Res       Date:  2016-04-22       Impact factor: 0.597

7.  Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome.

Authors:  Lior Zilberberg; Colin K L Phoon; Ian Robertson; Branka Dabovic; Francesco Ramirez; Daniel B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-22       Impact factor: 11.205

8.  Analysis of disease progression-associated gene expression profile in fibrillin-1 mutant mice: new insight into molecular pathogenesis of marfan syndrome.

Authors:  Koung Li Kim; Chanmi Choi; Wonhee Suh
Journal:  Biomol Ther (Seoul)       Date:  2014-02       Impact factor: 4.634

9.  Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.

Authors:  Philipp Christian Seppelt; Simon Schwill; Alexander Weymann; Rawa Arif; Antje Weber; Marcin Zaradzki; Karsten Richter; Stephan Ensminger; Peter Nicholas Robinson; Andreas H Wagner; Matthias Karck; Klaus Kallenbach
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

10.  AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome.

Authors:  Rawa Arif; Marcin Zaradzki; Anca Remes; Philipp Seppelt; Reiner Kunze; Hannes Schröder; Simon Schwill; Stephan M Ensminger; Peter N Robinson; Matthias Karck; Oliver J Müller; Markus Hecker; Andreas H Wagner; Klaus Kallenbach
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.